Skip to main content

MCQ. Mavacamten

 Q. Mavacamten was recently assessed and found to be useful in which of the following disease?

A. DCMP

B. HOCM

C. Coronary artery disease with mitral regurgitation

D. Amyloidosis


Answer: B. HOCM

Mavacamten is a medication that relaxes the heart muscle and treats obstructive hypertrophic cardiomyopathy (HCM). It is a small-molecule inhibitor of cardiac myosin that reduces myocardial contractility and improves myocardial energetics.

Labels:

Comments

Post a Comment

Popular posts from this blog

ECG Spotter

What is the diagnosis? Click the button below to view answer: Show Answer
Post a Comment
Read more

MCQ

 Cardiology MCQ Q. Which of the following leads is not an inferior lead in ECG? A. Lead II B. Lead III C. Lead aVF D. Lead aVR Click the button below to view answer Show answer Correct answer is option D. Lead aVR
Post a Comment
Read more

Peripartum Cardiomyopathy

Peripartum Cardiomyopathy  (PPCM) •         Usually develops in last month of pregnancy or first 5 months post-delivery. •         Presents as heart failure with reduced ejection fraction (dilated cardiomyopathy) ↳        LV EF < 45%  •         PPCM is a diagnosis of exclusion. •         Risk factors → 1-      History of Hypertension, Pre-eclampsia 2-      Black women •         Incidence → 1 in 2000 live births. •         Management → 1.       Guideline directed medical therapy for HF- Beta-blockers Hydralazine plus isosorbide dinitrate  Diuretics 2.       Bromocriptine 3.       Low threshold for anticoagulation 4. ...
Post a Comment
Read more